FAIANO, PIERANGELO
 Distribuzione geografica
Continente #
NA - Nord America 469
EU - Europa 184
AS - Asia 76
AF - Africa 6
SA - Sud America 1
Totale 736
Nazione #
US - Stati Uniti d'America 465
IT - Italia 114
SG - Singapore 28
AT - Austria 26
IN - India 25
CN - Cina 17
FI - Finlandia 11
SE - Svezia 11
DE - Germania 8
TG - Togo 6
BG - Bulgaria 4
CA - Canada 3
NL - Olanda 3
GB - Regno Unito 2
IE - Irlanda 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BE - Belgio 1
FR - Francia 1
ID - Indonesia 1
IR - Iran 1
KZ - Kazakistan 1
MX - Messico 1
UA - Ucraina 1
Totale 736
Città #
Fairfield 76
Rome 36
Ashburn 35
Seattle 33
Woodbridge 28
Ann Arbor 25
Singapore 23
Vienna 23
Wilmington 23
Chandler 22
Dearborn 20
Houston 20
Cambridge 18
Princeton 16
Florence 14
Plano 10
Helsinki 8
Boston 7
Redwood City 7
Beijing 6
Lomé 6
New York 6
Andover 5
Norwalk 5
Santa Clara 5
Bremen 4
Gurgaon 4
Hefei 4
Millbury 4
Sofia 4
Torino 4
Casoria 3
Ercolano 3
Lawrence 3
Barnsley 2
Battipaglia 2
Calenzano 2
Dublin 2
Karachi 2
Largo 2
Nanjing 2
Palermo 2
San Diego 2
San Giovanni Valdarno 2
San Paolo di Civitate 2
Toronto 2
Bari 1
Brussels 1
Buffalo 1
Camaiore 1
Catania 1
Clearwater 1
Des Moines 1
Dubai 1
Falkenstein 1
Federal 1
Fuzhou 1
Guangzhou 1
Hebei 1
Helmond 1
Jakarta 1
Kunming 1
Marino 1
Mexico City 1
Pathanamthitta 1
Perugia 1
Phoenix 1
Pisa 1
Pune 1
Raritan 1
Ridder 1
Sacramento 1
Seregno 1
Shaoxing 1
Vasanello 1
Verona 1
Totale 564
Nome #
Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers 106
null 96
Prevention of recurrent lower urinary tract infections in postmenopausal women with genitourinary syndrome. outcome after 6 months of treatment with ospemifene 95
A medical device containing purified bovine colostrum (Monurelle Biogel) in the treatment of vulvovaginal atrophy in postmenopausal women: Retrospective analysis of urinary symptoms, sexual function, and quality of life 93
Efficacy and tolerability of treatment with mirabegron compared with solifenacin in the management of overactive bladder syndrome: a retrospective analysis 77
Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks. improvement in overactive bladder symptoms 71
null 65
Improvement of QoL after hormone replacement therapy in cervical cancer survivors 49
Vaginal Native Tissue Repair for Posterior Compartment Prolapse. Long-Term Analysis of Sexual Function and Quality of Life in 151 Patients 41
improvement of qol after hormone replacement therapy in cervical cancer survivors 39
Uterine undifferentiated sarcoma associated with primary adenocarcinoid of ileum: an unusual second primary malignancy with therapeutic implications 28
Early Diagnosis of Congenital Uterine Anomalies: Is the Three Dimensional Ultrasound Approach the Suitable Choice? 3D in Uterine Anomalies 22
TRABECTEDIN PLUS CISPLATIN IN RECURRENT OR METASTATIC CERVICAL CANCER. A PHASE I-II DOSE-FINDING STUDY 14
Totale 796
Categoria #
all - tutte 1.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.967


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020131 0 0 0 4 16 29 25 14 16 8 9 10
2020/202155 5 2 2 4 2 3 1 9 8 8 7 4
2021/2022111 0 3 9 5 12 10 4 10 9 6 20 23
2022/2023138 34 15 8 17 17 12 3 12 16 0 4 0
2023/202475 5 7 1 3 10 14 0 13 0 9 8 5
2024/202533 4 16 11 2 0 0 0 0 0 0 0 0
Totale 796